Juan Camilo Arjona Ferreira - Jan 4, 2023 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Jan 4, 2023
Transactions value $
-$60,552
Form type
4
Date filed
1/5/2023, 04:21 PM
Previous filing
Oct 20, 2022
Next filing
Jan 20, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale -$60.6K -2.25K -0.9% $26.90 248K Jan 4, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.